300639.SZ Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 10:04):

Guangdong Hybribio Biotech Co.,Ltd. engages in the research and development, manufacture, and sale of nucleic acid molecular diagnostic products for hospitals and medical institutes...

Stats
Dzisiejszy wolumen	7.55M
Średni wolumen	7.15M
Kapitalizacja rynkowa	4.03B
EPS	CNY0 ( 2023-10-25 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	10.10
ATR14	CNY0.0110 (0.18%)

Wolumen Korelacja

Długi: 0.00 (neutral)

Krótki: 0.00 (neutral)

Signal:(40.853) Neutral

Guangdong Hybribio Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Guangdong Hybribio Korelacja - Waluta/Towar

0.53
( weak )

0.21
( neutral )

0.00
( neutral )

0.45
( neutral )

-0.50
( weak negative )

0.17
( neutral )

Guangdong Hybribio Finanse

Annual	2022
Przychody:	CNY5.60B
Zysk brutto:	CNY3.88B (69.36 %)
EPS:	CNY2.65

FY	2022
Przychody:	CNY5.60B
Zysk brutto:	CNY3.88B (69.36 %)
EPS:	CNY2.65

FY	2021
Przychody:	CNY2.67B
Zysk brutto:	CNY1.81B (67.63 %)
EPS:	CNY3.12

FY	2020
Przychody:	CNY1.35B
Zysk brutto:	CNY993.74M (73.37 %)
EPS:	CNY1.327

Financial Reports:

No articles found.

Guangdong Hybribio

Guangdong Hybribio Biotech Co.,Ltd. engages in the research and development, manufacture, and sale of nucleic acid molecular diagnostic products for hospitals and medical institutes. It provides in-vitro diagnostic kits for human papilloma virus, sexually transmitted diseases (STD), thalassemia, and prenatal and postnatal. The company also offers STD real time PCR kits; hepatitis B virus real-time PCR kits and thalassemia genoarray diagnostic kits; hearing loss susceptibility genoarray diagnostic kits; COVID-19 real-time PCR kits; and devices/instruments, including automated nucleic acid extraction, automatic medical PCR analysis, flow-through hybridization, auto DNA extraction, and fluorescent quantitative detection systems, as well as after-sales technical service support. Its products are used in the fields of national screening, clinical, and research purposes. The company operates in the Asia Pacific, the South East Asia, the Middle East, Europe, Africa, and South America. Guangdong Hybribio Biotech Co.,Ltd. was founded in 2003 and is based in Sheung Wan, Hong Kong.